Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review

Marianne Fitzgerald, Jonathan Millar, Bronagh Blackwood, Andrew Davies, Stephen J Brett, Daniel F McAuley, James J McNamee, Marianne Fitzgerald, Jonathan Millar, Bronagh Blackwood, Andrew Davies, Stephen J Brett, Daniel F McAuley, James J McNamee

Abstract

Acute respiratory distress syndrome (ARDS) continues to have significant mortality and morbidity. The only intervention proven to reduce mortality is the use of lung-protective mechanical ventilation strategies, although such a strategy may lead to problematic hypercapnia. Extracorporeal carbon dioxide removal (ECCO₂R) devices allow uncoupling of ventilation from oxygenation, thereby removing carbon dioxide and facilitating lower tidal volume ventilation. We performed a systematic review to assess efficacy, complication rates, and utility of ECCO₂R devices. We included randomised controlled trials (RCTs), case-control studies and case series with 10 or more patients. We searched MEDLINE, Embase, LILACS (Literatura Latino Americana em Ciências da Saúde), and ISI Web of Science, in addition to grey literature and clinical trials registries. Data were independently extracted by two reviewers against predefined criteria and agreement was reached by consensus. Outcomes of interest included mortality, intensive care and hospital lengths of stay, respiratory parameters and complications. The review included 14 studies with 495 patients (two RCTs and 12 observational studies). Arteriovenous ECCO₂R was used in seven studies, and venovenous ECCO₂R in seven studies. Available evidence suggests no mortality benefit to ECCO₂R, although post hoc analysis of data from the most recent RCT showed an improvement in ventilator-free days in more severe ARDS. Organ failure-free days or ICU stay have not been shown to decrease with ECCOvR. Carbon dioxide removal was widely demonstrated as feasible, facilitating the use of lower tidal volume ventilation. Complication rates varied greatly across the included studies, representing technological advances. There was a general paucity of high-quality data and significant variation in both practice and technology used among studies, which confounded analysis. ECCO₂R is a rapidly evolving technology and is an efficacious treatment to enable protective lung ventilation. Evidence for a positive effect on mortality and other important clinical outcomes is lacking. Rapid technological advances have led to major changes in these devices and together with variation in study design have limited applicability of analysis. Further well-designed adequately powered RCTs are needed.

Figures

Figure 1
Figure 1
Literature search. LILACS, Literatura Latino Americana em Ciências da Saúde.

References

    1. Villar J, Blanco J, Anon JM, Santos-Bouza A, Blanch L, Ambros A, Gandia F, Carriedo D, Mosteiro F, Basaldua S, Fernandez RL, Kacmarek RM. ALIEN Network. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011;37:1932–1941. doi: 10.1007/s00134-011-2380-4.
    1. Tremblay LN, Slutsky AS. Ventilator-induced lung injury: from the bench to the bedside. Intensive Care Med. 2006;32:24–33. doi: 10.1007/s00134-005-2817-8.
    1. ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308.
    1. Rubenfeld GD, Cooper C, Carter G, Thompson BT, Hudson LD. Barriers to providing lung-protective ventilation to patients with acute lung injury. Crit Care Med. 2004;32:1289–1293. doi: 10.1097/01.CCM.0000127266.39560.96.
    1. Cove ME, Maclaren G, Federspiel WJ, Kellum JA. Bench to bedside review: Extracorporeal carbon dioxide removal, past present and future. Crit Care. 2012;16:232. doi: 10.1186/cc11356.
    1. Gattinoni L, Kolobow T, Tomlinson T, Iapichino G, Samaja M, White D, Pierce J. Low-frequency positive pressure ventilation with extracorporeal carbon dioxide removal (LFPPV-ECCO2R): an experimental study. Anesth Analg. 1978;57:470–477.
    1. Gattinoni L, Kolobow T, Tomlinson T, White D, Pierce J. Control of intermittent positive pressure breathing (IPPB) by extracorporeal removal of carbon dioxide. Br J Anaesth. 1978;50:753–758. doi: 10.1093/bja/50.8.753.
    1. Brunet F, Belghith M, Mira JP, Lanore JJ, Vaxelaire JF, Dall'ava Santucci J, Dhainaut JF. Extracorporeal carbon dioxide removal and low-frequency positive-pressure ventilation. Improvement in arterial oxygenation with reduction of risk of pulmonary barotrauma in patients with adult respiratory distress syndrome. Chest. 1993;104:889–898. doi: 10.1378/chest.104.3.889.
    1. Moerer O, Quintel M. Protective and ultra-protective ventilation: using pumpless interventional lung assist (iLA) Minerva Anestesiol. 2011;77:537–544.
    1. Fitzgerald M, Millar J, Blackwood B, Davies A, Brett SJ, McAuley DF, McNamee JJ. Effectiveness of extra-corporeal CO2 removal for patients with respiratory failure secondary to adult respiratory distress syndrome. PROSPERO International Prospective Register of Systematic Reviews. [ ]
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.
    1. ClinicalTrials. [ ]
    1. Current Controlled Trials. [ ]
    1. NIHR Portal. [ ]
    1. UK Critical Appraisal Skills Programme. [ ]
    1. Chan K, Bhandari M. Three-minute critical appraisal of a case series. Indian J Orthop. 2011;45:103–104. doi: 10.4103/0019-5413.77126.
    1. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [ ]
    1. Morris AH, Wallace CJ, Menlove RL, Clemmer TP, Orme JF Jr, Weaver LK, Dean NC, Thomas F, East TD, Pace NL, Suchyta MR, Beck E, Bombino M, Sittig DF, Böhm S, Hoffmann B, Becks H, Butler S, Pearl J, Rasmusson B. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994;149(2 Pt 1):295–305.
    1. Bein T, Weber-Carstens S, Goldmann A, Müller T, Staudinger T, Brederlau J, Muellenbach R, Dembinski R, Graf BM, Wewalka M, Philipp A, Wernecke KD, Lubnow M, Slutsky AS. Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med. 2013;39:847–856. doi: 10.1007/s00134-012-2787-6.
    1. Zimmermann M, Bein T, Arlt M, Philipp A, Rupprecht L, Mueller T, Lubnow M, Graf BM, Schlitt HJ. Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care. 2009;13:R10. doi: 10.1186/cc7703.
    1. Terragni PP, Del Sorbo L, Mascia L, Urbino R, Martin EL, Birocco A, Faggiano C, Quintel M, Gattinoni L, Ranieri VM. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology. 2009;111:826–835. doi: 10.1097/ALN.0b013e3181b764d2.
    1. Guinard N, Beloucif S, Gatecel C, Mateo J, Payen D. Interest of a therapeutic optimization strategy in severe ARDS. Chest. 1997;111:1000–1007. doi: 10.1378/chest.111.4.1000.
    1. Brunet F, Mira JP, Belghith M, Monchi M, Renaud B, Fierobe L, Hamy I, Dhainaut JF, Dall'ava-Santucci J. Extracorporeal carbon dioxide removal technique improves oxygenation without causing overinflation. Am J Respir Crit Care Med. 1994;149:1557–1562. doi: 10.1164/ajrccm.149.6.8004313.
    1. Gattinoni L, Pesenti A, Mascheroni D, Marcolin R, Fumagalli R, Rossi F, Iapichino G, Romagnoli G, Uziel L, Agostoni A, Kolobow T, Damia G. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA. 1986;256:881–886. doi: 10.1001/jama.1986.03380070087025.
    1. Forster C, Schriewer J, John S, Eckardt KU, Willam C. Low-flow CO2 removal integrated into a renal-replacement circuit can reduce acidosis and decrease vasopressor requirements. Crit Care. 2013;17:R154. doi: 10.1186/cc12833.
    1. Weber-Carstens S, Bercker S, Hommel M, Deja M, MacGuill M, Dreykluft C, Kaisers U. Hypercapnia in late-phase ALI/ARDS: providing spontaneous breathing using pumpless extracorporeal lung assist. Intensive Care Med. 2009;35:1100–1105. doi: 10.1007/s00134-009-1426-3.
    1. Muellenbach RM, Kredel M, Wunder C, Küstermann J, Wurmb T, Schwemmer U, Schuster F, Anetseder M, Roewer N, Brederlau J. Arteriovenous extracorporeal lung assist as integral part of a multimodal treatment concept: a retrospective analysis of 22 patients with ARDS refractory to standard care. Eur J Anaesthesiol. 2008;25:897–904. doi: 10.1017/S0265021508004870.
    1. Bein T, Weber F, Philipp A, Prasser C, Pfeifer M, Schmid FX, Butz B, Birnbaum D, Taeger K, Schlitt HJ. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med. 2006;34:1372–1377. doi: 10.1097/.
    1. Nierhaus A, Frings D, Braune S, Baumann HJ, Schneider C, Wittenburg B, Kluge S. Interventional lung assist enables lung protective mechanical ventilation in acute respiratory distress syndrome. Minerva Anestesiol. 2011;77:797–801.
    1. Liebold A, Philipp A, Kaiser M, Merk J, Schmid FX, Birnbaum DE. Pumpless extracorporeal lung assist using an arterio-venous shunt. Applications and limitations. Minerva Anestesiol. 2002;68:387–391.
    1. Bindslev L, Böhm C, Jolin A, Hambraeus Jonzon K, Olsson P, Ryniak S. Extracorporeal carbon dioxide removal performed with surface-heparinized equipment in patients with ARDS. Acta Anaesthesiol Scand Suppl. 1991;95:125–130.
    1. Mattei N, Mocavero P, Corcione A. Extracorporeal CO2 removal in ICU [abstract] Eur J Anaesthesiol. 2011;28(Suppl):170.
    1. Atalan HK, Dumantepe M, Denizalti TB, Tarhan IA, Ozler A. Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients [abstract] Crit Care. 2013;17(Suppl):S23.
    1. Health Quality Ontario. Extracorporeal lung support technologies – bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10:1–47.
    1. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, Gattas DJ, Hallett D, Tomlinson G, Stewart TE, Ferguson ND. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med. 2009;179:220–227. doi: 10.1164/rccm.200805-722OC.
    1. Terpstra ML, Aman J, van Nieuw Amerongen GP, Groeneveld AB. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2014;42:691–700. doi: 10.1097/01.ccm.0000435669.60811.24.
    1. Tzouvelekis A, Pneumatikos I, Bouros D. Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator. Respir Res. 2005;6:62. doi: 10.1186/1465-9921-6-62.
    1. Knoch M, Köllen B, Dietrich G, Müller E, Mottaghy K, Lennartz H. Progress in veno-venous long-term bypass techniques for the treatment of ARDS. Controlled clinical trial with the heparin-coated bypass circuit. Int J Artif Organs. 1992;15:103–108.
    1. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani D. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 2005;33:1191–1198. doi: 10.1097/01.CCM.0000165566.82925.14.
    1. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409–417. doi: 10.1056/NEJM199902113400601.
    1. Strøm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients. Lancet. 2010;375:475–480. doi: 10.1016/S0140-6736(09)62072-9.
    1. Shehabi Y, Bellomo R, Reade MC, Bailey M, Bass F, Howe B, McArthur C, Seppelt IM, Webb S, Weisbrodt L. Sedation Practice in Intensive Care Evaluation (SPICE) Study Investigators; ANZICS Clinical Trials Group. Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med. 2012;186:724–731. doi: 10.1164/rccm.201203-0522OC.
    1. Laffey JG, Honan D, Hopkins N, Hyvelin JM, Boylan JF, McLoughlin P. Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am J Respir Crit Care Med. 2004;169:46–56. doi: 10.1164/rccm.200205-394OC.
    1. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282:54–61. doi: 10.1001/jama.282.1.54.
    1. Harbour R, Miller J. Scottish Intercollegiate Guidelines Network Grading Review Group. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323:334–336.
    1. Extracorporeal Membrane Carbon Dioxide Removal. NICE interventional Procedure Guidance 428. [ ]
    1. Flow-flow ECCO2-R and 4 ml/kg Tidal Volume vs. 6 ml/kg Tidal Volume to Enhance Protection From VILI in Acute Lung Injury. [ ]
    1. Pulmonary and Renal Support During Acute Respiratory Distress Syndrome. [ ]

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi